Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0185 | 0.0966 | 0.9757 |
Toxoplasma gondii | leucyl aminopeptidase LAP | 0.012 | 0.0543 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.0668 | 0.3757 |
Mycobacterium ulcerans | DNA-directed RNA polymerase subunit beta | 0.158 | 1 | 1 |
Mycobacterium leprae | DNA-DIRECTED RNA POLYMERASE (BETA CHAIN) RPOB (TRANSCRIPTASE BETA CHAIN) (RNA POLYMERASE BETA SUBUNIT) | 0.158 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0311 | 0.1778 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0139 | 0.0668 | 0.4128 |
Onchocerca volvulus | 0.0286 | 0.1619 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.099 | 0.5565 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0041 | 0.0033 | 0.0601 |
Schistosoma mansoni | alpha-glucosidase | 0.0159 | 0.0799 | 0.4491 |
Brugia malayi | glutaminase DH11.1 | 0.0311 | 0.1778 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0041 | 0.0033 | 0.0184 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.1619 | 0.9086 |
Onchocerca volvulus | Huntingtin homolog | 0.0139 | 0.0668 | 0.4128 |
Trypanosoma cruzi | metallo-peptidase, Clan MF, Family M17, putative | 0.012 | 0.0543 | 1 |
Leishmania major | cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 | 0.012 | 0.0543 | 1 |
Brugia malayi | hypothetical protein | 0.0139 | 0.0668 | 0.3757 |
Plasmodium vivax | M17 leucyl aminopeptidase, putative | 0.012 | 0.0543 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0041 | 0.0033 | 0.5 |
Plasmodium falciparum | DNA-directed RNA polymerase subunit beta, putative | 0.158 | 1 | 1 |
Treponema pallidum | DNA-directed RNA polymerase subunit beta | 0.158 | 1 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.0311 | 0.1778 | 0.1306 |
Echinococcus granulosus | geminin | 0.0189 | 0.099 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0311 | 0.1778 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.0668 | 0.3757 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0185 | 0.0966 | 0.543 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0185 | 0.0966 | 0.9757 |
Mycobacterium tuberculosis | DNA-directed RNA polymerase (beta chain) RpoB (transcriptase beta chain) (RNA polymerase beta subunit) | 0.158 | 1 | 1 |
Trypanosoma cruzi | cytosolic leucyl aminopeptidase, putative | 0.012 | 0.0543 | 1 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0041 | 0.0033 | 0.033 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0041 | 0.0033 | 0.0184 |
Onchocerca volvulus | 0.0107 | 0.046 | 0.2842 | |
Schistosoma mansoni | glutaminase | 0.0311 | 0.1778 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.1394 | 0.7838 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0041 | 0.0033 | 0.033 |
Echinococcus multilocularis | leucine aminopeptidase protein | 0.012 | 0.0543 | 0.5489 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0185 | 0.0966 | 0.543 |
Schistosoma mansoni | alpha glucosidase | 0.0041 | 0.0033 | 0.0184 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.099 | 0.5565 |
Echinococcus multilocularis | geminin | 0.0189 | 0.099 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0041 | 0.0033 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0185 | 0.0966 | 0.9757 |
Trypanosoma brucei | metallo-peptidase, Clan MF, Family M17 | 0.012 | 0.0543 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.1394 | 0.7838 |
Wolbachia endosymbiont of Brugia malayi | DNA-directed RNA polymerase subunit beta/beta' | 0.158 | 1 | 1 |
Echinococcus granulosus | leucine aminopeptidase protein | 0.012 | 0.0543 | 0.5489 |
Schistosoma mansoni | alpha-glucosidase | 0.0159 | 0.0799 | 0.4491 |
Loa Loa (eye worm) | glutaminase | 0.0311 | 0.1778 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.2387 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 20.5878 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.